(Q80332885)
Statements
Bortezomib therapy response is independent of cytogenetic abnormalities in relapsed/refractory multiple myeloma (English)
Hong Chang
Young Trieu
Xiaoying Qi
Wei Xu
Keith A Stewart
22 September 2006
scientific article published on 22 September 2006